Harry Kochat
17Patents
4h-index
9Co-inventors
49Inventor score
Filing activity: Apr 30, 2002 → Nov 13, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7759488B2 | Monoazole ligand platinum analogs | Human Necessities | 17 | Active |
| US6504049B1 | Process for synthesizing pharmaceutically active disulfide salts | Chemistry; Metallurgy | 7 | Expired |
| US7687496B2 | C7-substituted camptothecin analogs | Human Necessities | 6 | Active |
| US7060825B2 | Process for synthesizing 6-quinazolinyl-ethyl-benzoyl and related antifolates | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6977311B2 | Process for synthesizing L-γ-methylene glutamic acid and analogs | Chemistry; Metallurgy | 1 | Expired |
| US7030243B1 | Process for making camptothecin derivatives | Chemistry; Metallurgy | 1 | Expired |
| US7282602B2 | Medicinal disulfide salts | Human Necessities | 1 | Expired |
| US6723849B1 | Process for making camptothecin derivatives | Chemistry; Metallurgy | 1 | Expired |
| US7829540B2 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents | Human Necessities | 0 | Active |
| US7829538B2 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents | Human Necessities | 0 | Active |
| US7268244B2 | Monoimine ligand platinum analogs | Human Necessities | 0 | Expired |
| US8569265B2 | Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3′, 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof | Human Necessities | 0 | Active |
| US7829117B2 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents | Human Necessities | 0 | Active |
| US7687497B2 | C10-substituted camptothecin analogs | Human Necessities | 0 | Active |
| US8722886B1 | Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin | Chemistry; Metallurgy | 0 | Active |
| US7829541B2 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents | Human Necessities | 0 | Active |
| US7829539B2 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.